Abstract
The emergence of novel coronaviruses requires new and innovative approaches in development of broad-spectrum antiviral therapeutics. Targeting and inhibiting replication machineries of pathogenic viruses is a proven and effective anti-viral strategy. Similar to other +RNA viruses, coronavirus genomic replication and transcription are moderated by an RNA replication-transcription complex (RTC) anchored in rearranged internal host membranes. The hallmark of coronavirus-induced membrane rearrangements is double-membrane vesicles (DMVs), named for their distinctive double-lipid bilayer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
